金澤美真理先生の論文が、Medicina (Journal Citation Reports Impact Factor 2020 = 2.430)にacceptされました。

Medicina (Kaunas). 2022 Feb 11;58(2):276. doi: 10.3390/medicina58020276.

A Case of Stevens-Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis

Mimari Kanazawa, Keiichi Tominaga, Akira Kanamori, Takanao Tanaka, Satoshi Masuyama, Shoko Watanabe, Keiichiro Abe, Akira Yamamiya, Kenichi Goda, Atsushi Irisawa

Affiliations expand
PMID: 35208599 PMCID: PMC8876713 DOI: 10.3390/medicina58020276
Free PMC article

Abstract
A 41-year-old man was treated with prednisolone (PSL) and multimatrix (MMX) mesalamine for remission induction therapy of ulcerative colitis. PSL was tapered due to successful remission induction treatment. During the treatment course, ocular foreign body sensation, eyelid swelling, ocular conjunctiva hyperemia, facial redness and swelling, watery nasal discharge, stomatitis, anal pain, and reddish puffiness on the bilateral dorsum of the hands appeared, and he was diagnosed with Stevens-Johnson syndrome (SJS). SJS was improved by PSL treatment and intravenous immunoglobulin. MMX mesalamine was the causative agent by drug-induced lymphocyte stimulation test. This is the first reported case of SJS with MMX mesalamine.

Keywords: Stevens–Johnson syndrome; multimatrix system mesalamine; severe adverse event; ulcerative colitis.

https://pubmed.ncbi.nlm.nih.gov/35208599/